Marlins pitcher Nic Enright undergoing treatment for Hodgkin’s lymphoma

Marlins right-hander Nic Enright announced on social media that he was diagnosed with Hodgkin’s lymphoma in December, relayed by Craig Mish of the Miami Herald. It’s unclear what is next for Enright, but he does state that he has already completed the first round of treatments.

“My goal is to use my platform to provide hope and inspiration to others who fight their battles with cancer,” he said in his post. “I’m going to continue to tackle this challenge with the same perseverance that I do baseball – and I can’t wait to return to the mound and the game I love. I might have cancer, but cancer does not have me!”

Enright, 26, was drafted by Cleveland in the 20th round of the 2019 draft. He worked his way up the minor league ladder and spent last year split between Double-A and Triple-A. He tossed 65 2/3 innings between those two levels in 2022, posting a 2.88 ERA with a 33.7% strikeout rate and 5.4% walk rate. He was left unprotected prior to the Rule 5 draft in December, which allowed the Marlins to select him.

Enright was lined up to battle for a spot in the Miami bullpen and perhaps make his major league debut this year, but baseball will now take a backburner as he focuses on the much more important issue of his health. We at MLB Trade Rumors wish him all the best in his recovery and look forward to seeing him on the mound again in the future. He’s the second pitcher to reveal a cancer diagnosis in as many months, as Liam Hendriks of the White Sox announced in January that he was diagnosed with non-Hodgkin’s lymphoma.